Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2353${count})

  • Research Grant, 2019
    Mechanistic Characterization of the PINK1-amplifying Compound MTK-458

    Study Rationale:
    Loss-of-function mutations in components of the PINK1/PRKN pathway lead to early onset Parkinson’s disease. Previous work by our company has shown that our compounds can amplify the...

  • Research Grant, 2019
    Supplement: Investigation of PINK1-dependent Phosphorylation of Rab GTPases

    Promising Outcomes of Original Grant:
    We were trying to understand how the PINK1 gene targets a set of proteins known as Rab GTPases through protein modification known as phosphorylation. The...

  • Research Grant, 2019
    PPM1H Activators for the Treatment of Parkinson’s Disease

    Study Rationale:
    Although Parkinson’s disease (PD) causes are in most cases unknown (idiopathic) some cases are linked to a person’s genetics. Leucine-rich repeat kinase 2 (LRRK2) is a very important...

  • Epidemiological Parkinson's Risk Modifiers, 2019
    Study in Finnish Population to Identify Therapies with Repurposing Potential for Parkinson’s Disease

    Study Rationale:
    Effective treatments for slowing the progression of Parkinson’s disease are urgently needed. Searching for possible treatments among drugs already used for other indications is a...

  • Therapeutic Pipeline Program, 2019
    Biomaterial-enhanced Cellular Brain Repair for Parkinson's Disease

    Study Rationale:
    One promising approach for the treatment of Parkinson’s is to replace the cells that have died in the disease through transplantation of healthy cells into the brain. However, this...

  • Target Advancement Program, 2019
    Connexins as a New Therapeutic Target to Impede Spreading of Alpha-synuclein Pathology

    Study Rationale:
    Direct cellular connectivity has recently been implicated in the transfer of alpha-synuclein pathology associated with Parkinson’s disease. The gap junction proteins known as...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.